Stemedica Cell Technologies, Inc.

Stemedica is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics.

[Stemedica Cell Technologies, Inc. @stemedica]

Stemedica Reports Positive Data in Phase I/IIa Study of Allogeneic Stem Cells for Ischemic Stroke.
#stemcells #ischemicstroke #FDA #Stemedica #JPM19 https://t.co/342IZKyIKO

[Alliance for Regenerative Medicine (ARM) @alliancerm]

CardioCell, new spin-off from @stemedica beginning mid-stage clinical study to treat heart attacks @Xconomy http://t.co/aLLyRJWDyV

[Biocom @Biocom]

@Stemedica's CardioCell begins clinical study of proprietary #stemcells to treat #heartattack patients. @XconomySD http://t.co/uNDIQojIsR